Cue Biopharma
75 hedge funds and large institutions have $17.1M invested in Cue Biopharma in 2024 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 15 increasing their positions, 22 reducing their positions, and 22 closing their positions.
Holders
75
Holders Change
-2
Holders Change %
-2.6%
% of All Funds
1.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
15
Reduced
22
Closed
22
Calls
$279K
Puts
$18K
Net Calls
+$261K
Net Calls Change
+$57K
Top Buyers
| 1 |
GLA
1
Good Life Advisors
Reading,
Pennsylvania
|
$403K |
| 2 |
2
Goldman Sachs
New York
|
$330K |
| 3 |
YIH
3
Y-Intercept (HK)
Hong Kong
|
$191K |
| 4 |
4
Millennium Management
New York
|
$613K |
| 5 |
BL
5
Bleichroeder LP
New York
|
$3.55M |
